Chemoinformaics analysis of N-METHYL-3-CYANOPYRIDONE
| Molecular Weight | 134.138 | nRot | 0 |
| Heavy Atom Molecular Weight | 128.09 | nRig | 8 |
| Exact Molecular Weight | 134.048 | nRing | 1 |
| Solubility: LogS | -1.057 | nHRing | 1 |
| Solubility: LogP | 0.052 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 18.6928 |
| nHD | 0 | BPOL | 9.16724 |
| QED | 0.51 |
| Synth | 2.4 |
| Natural Product Likeliness | -1.81 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.537 |
| MDCK | 0.0000342 |
| BBB | 0.525 |
| PPB | 0.290866 |
| VDSS | 0.802 |
| FU | 0.695529 |
| CYP1A2-inh | 0.397 |
| CYP1A2-sub | 0.893 |
| CYP2c19-inh | 0.098 |
| CYP2c19-sub | 0.252 |
| CYP2c9-inh | 0.026 |
| CYP2c9-sub | 0.539 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.435 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.407 |
| CL | 6.724 |
| T12 | 0.832 |
| hERG | 0.014 |
| Ames | 0.247 |
| ROA | 0.826 |
| SkinSen | 0.185 |
| Carcinogencity | 0.75 |
| EI | 0.94 |
| Respiratory | 0.083 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.817585 |